By Scientia Professor John Martin Kaldor

Journal articles

MacDonald MA; Wodak AD; Dolan K; Van Beek IA; Cunningham PH; Kaldor JM, 2000, 'Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61

Wodak AD; Van Beek IA; Kaldor JM, 2000, 'Hepatitus C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61

Butler T; Donovan BJ; Taylor J; Cunningham AL; Mindel A; Levy MT; Kaldor JM; Butler , 2000, 'Herpes simplex virus type 2 in prisoners, New South Wales, Australia', International Journal of STD and AIDS, 11, pp. 743 - 747

Guthrie J; Dore GJ; McDonald AM; Kaldor JM; For TNHS, 2000, 'HIV and AIDS in Aboriginal and Torres Strait Islander Australians:1992-1998', Medical Journal of Australia, 172, pp. 266 - 269

Li Y; McDonald AM; Dore GJ; Kaldor JM; For TNHS, 2000, 'Improving survival following AIDS in Australia, 1991-1996', AIDS, 14, pp. 2349 - 2354

Irwin M; Carr A; Kaldor J, 2000, 'P37 The relationship between physical activity and HIV lipodystrophy syndrome in protease inhibitor recipients', HIV Medicine, 1, pp. 184 - 184, http://dx.doi.org/10.1046/j.1468-1293.2000.00024-121.x

Law MG; Roberts S; Dore GJ; Kaldor JM, 2000, 'Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality', Medical Journal of Australia, 173, pp. 403 - 405

Kaldor JM, 2000, 'Reflections on a decade of HIV/AIDS surveillance in Australia', Australian HIV Surveillance Report, 16, pp. 1 - 4

Ashton LJ; Kaldor JM, 2000, 'The historical development of epidemiological methods for studying HIV-1 disease progression', Journal of Epidemiology and Biostatistics, pp. 67 - 78

Kaldor JM; Dore GJ; Correll PK, 2000, 'Towards control of hepatitis C in the Asia-Pacific region ¿ Public health challenges in hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 15, pp. E83 - E90

Sullivan LG; Crofts JN; Aitken CK; Kaldor JM, 1999, 'The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not (multiple letters) [3]', Medical Journal of Australia, 171, pp. 165 - 166, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123582.x

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1999, 'HIV disease progression in Australia in the time of combination antiretroviral therapies', MEDICAL JOURNAL OF AUSTRALIA, 170, pp. 285 - 285, http://dx.doi.org/10.5694/j.1326-5377.1999.tb127767.x

Crofts N; Aitken CK; Kaldor JM, 1999, 'The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not', Medical Journal of Australia, 170, pp. 220 - 221, http://dx.doi.org/10.5694/j.1326-5377.1999.tb140325.x

Kelly P; Cummings R; Kaldor JM; Irwig L, 1999, 'A new, clinically-based algorithm for the diagnosis of HIV in African tuberculosis patients: cross-sectional analysis from Mzuzu, Malawi', International Journal of STD and AIDS, 10, pp. 231 - 236

Grulich AE; Kaldor JM, 1999, 'AEA response to proposed Australian National Privacy Legislation', Australasian Epidemiologist, pp. 14 - 15

Law MG; De Winter L; McDonald AM; Cooper DA; Kaldor JM, 1999, 'AIDS-diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment', AIDS, 13, pp. 263 - 269

Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 13, pp. 1249 - 1253

Kelly P; Cumming RG; Kaldor JM, 1999, 'HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up', Transactions of the Royal Society of Tropical Medicine and Hygiene, pp. 287 - 293

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1999, 'HIV disease progression in Australia in the time of combination antiretroviral therapies. (Author's reply)', Medical Journal of Australia, 170, pp. 285 - 285 (letter)

McDonald AM; Ryan JL; Brown PJ; Manners CJ; Falconer AD; Kinnear RC; Harvey WJ; Hearne PR; Banaszczyk M; Kaldor JM, 1999, 'HIV prevalence at reception into Australian prisons, 1991-1997', Medical Journal of Australia, 171, pp. 18 - 21

Westley-Wise VJ; Stewart BW; Kreis I; Ricci PF; Hogan AL; Darling C; Corbett S; Kaldor JM; Stacey NH; Warburton P, 1999, 'Investigation of a cluster of leukaemia in the Illawarra region of New South Wales', Medical Journal of Australia, 171, pp. 178 - 183

Westley-Wise VJ; Stewart BW; Kreis I; Ricci PF; Hogan AL; Darling C; Corbett S; Kaldor JM; Stacey NH; Warburton P, 1999, 'Investigation of a cluster of leukaemia in the Illawarra region of New South Wales, 1989-1996', Medical Journal of Australia, 171, pp. 178 - 183

Grulich AE; Olsen SJ; Luo K; Hendry O; Cunningham PH; Cooper DA; Gao SJ; Chang Y; Moore PH; Kaldor JM, 1999, 'Kaposi¿s sarcoma-associated herpesvirus: a sexually transmissible infection?', Journal of acquired immune deficiency syndrome and human retrovirology, 20, pp. 387 - 393

Dore GJ; Law MG; Kaldor JM, 1999, 'Prevalence of hepatitis C virus infection in the United States', New England Journal of Medicine, pp. 2093 - 2094 (lett

Grulich AE; Wan X; Law MG; Coates ML; Kaldor JM, 1999, 'Risk of cancer in people with AIDS', AIDS, 13, pp. 839 - 843

Butler T; Spencer J; Cui JS; Vickery K; Zou J; Kaldor JM; Butler , 1999, 'Seroprevalence of markers for hepatitis B, C and G in male and female prisoners ¿ NSW, 1996', Australian and New Zealand Journal of Public Health, pp. 377 - 384

Collins SL; Law MG; Fletcher A; Boyd AW; Kaldor JM; Masters C, 1999, 'Surgical treatment and risk of sporadic Creutzfeldt-Jacob disease: a case-control study', The Lancet, pp. 693 - 697

Crofts N; Aitken CK; Kaldor JM, 1999, 'The force of numbers: why hepatitis C is spreading among injecting Australian drug users while HIV is not', Medical Journal of Australia, 170, pp. 220 - 221

Crofts N; Aitken CK; Kaldor JM, 1999, 'The force of numbers: why hepatitis C is spreading among injecting Australian drug users while HIV is not. (Author¿s reply)', Medical Journal of Australia, 171, pp. 165 - 166 (lette

Crofts N; Loveday S; Kaldor JM, 1999, 'The meaning of hepatitis C for the community', Australian Family Physician, pp. 60 - 63

Collignon P; Dore GJ; Li Y; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates (multiple letters) [3]', Medical Journal of Australia, 169, pp. 444 - 448, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126845.x

Kippax S; Rosenthal D; Dowsett G; Kaldor J; Crofts N; McCallum L; Brotherton A, 1998, 'AIDS impact.', AIDS care, 10 Suppl 2

Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C - Summary vertical transmission rates may be misleading - Reply', BRITISH MEDICAL JOURNAL, 316, pp. 554 - 554, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072097400048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas S; Hall A; Newell ML; Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C (multiple letters) [5]', British Medical Journal, 316, pp. 553 - 554

Skov S; Tait P; Kaldor JM; Bowden FJ, 1998, 'A field trial of azithromycin in the treatment of donovanosis in Central Australia: a step towards eradiaction?', Venereology - the Interdisciplinary International Journal of Sexual Health, 11, pp. 11 - 14

Kaldor JM, 1998, 'AIDS in Asia and the Pacific Second edition', AIDS, 12

Cui JS; Kaldor JM, 1998, 'Changing pattern of delays in reporting AIDS diagnoses in Australia', Australian and New Zealand Journal of Public Health, pp. 432 - 435

Boffetta P; Fichtinger-Schepman AM; Weiderpass E; Van Dijk-Knijnenburg HC; Stoter G; Van Oosterom AT; Keizer HJ; Fossa SD; Kaldor JM; Roy P, 1998, 'Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients', Anti-Cancer Drugs, pp. 125 - 129

Kippax SC; Campbell DK; Van De Ven PG; Crawford G; Prestage G; Knox SJ; Culpin A; Kaldor JM; Kinder P, 1998, 'Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 10, pp. 677 - 688

Crofts JN; Dore GJ; Kaldor JM; Law MG; Wodak AD; Et A, 1998, 'Estimates and projections of the hepatitis C virus epidemic in Australia', ION Meeting Proceedings

Dore GJ; Brown TA; Tarantola D; Kaldor JM, 1998, 'HIV and AIDS in the Asia-Pacific region: an epidemiological overview', AIDS, 12, pp. S1 - S10

MacDonald MA; Sullivan PJ; Lock A; Wodak AD; Kaldor JM, 1998, 'HIV and HCV prevalence among fishing trawler crew', Australian and New Zealand Journal of Public Health, pp. 829 - 831

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1998, 'HIV disease progression in Australia in the time of combination antiretroviral therapies', Medical Journal of Australia, 169, pp. 469 - 472

Thackway S; Furner V; Mijch AM; Cooper DA; Holland D; Martinez P; Shaw D; Van Beek IA; Wright E; Clezy KR; Kaldor JM, 1998, 'HIV infection in women in the Asia-Pacific region: the Australian experience', Journal of Hiv Therapy, pp. 9 - 12

Kaldor JM; Bharat S; Brown TA; Chan RC; Zhang K, 1998, 'HIV/AIDS in the Asia-Pacific region: the road remains long', AIDS, 12, pp. I - ii

Van Beek IA; Dwyer RG; Dore GJ; Luo K; Kaldor JM, 1998, 'Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study', British Medical Journal: International, pp. 433 - 437

Van Bentham BH; Veugelers PJ; Cornelisse PG; Strathdee S; Kaldor JM; Page-Shafer K; Coutinho RA; Van Griensven GJ, 1998, 'Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study', AIDS, 12, pp. 1039 - 1045

Dore GJ; Grulich AE; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi¿s sarcoma and protection from AIDS dementia complex', AIDS, 12, pp. 2354 - 2355

Dore GJ; Kaldor JM; Mccaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C', British Medical Journal: International, pp. 553 - 554

Ashton LJ; Carr AD; Cunningham PH; Roggensack M; Mclean K; Law MG; Robertson M; Cooper DA; Kaldor JM, 1998, 'Predictors of progression in long-term nonprogressors.', AIDS Research and Human Retroviruses, 14, pp. 117 - 121

Back to profile page